| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |